Joshua Kovach

Joshua Kovach

Auto-generated profile, based on publicly available information

Joshua Kovach

Medical College of Wisconsin

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2020 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
MBMadeline Bireley
Madeline Bireley
JKJoshua R. Kovach
Joshua R. Kovach
CMCandace Morton
Candace Morton
JCJoseph R. Cava
Joseph R. Cava
APAmy Pan
Amy Pan
MSMargaret M. Samyn
Margaret M. Samyn

1 May 2020 in Heart Rhythm
Verified
Journal Article
Closed access
JKJoshua R. Kovach
Joshua R. Kovach
DMDouglas Y. Mah
Douglas Y. Mah
DADominic J. Abrams
Dominic J. Abrams
MAMark E. Alexander
Mark E. Alexander
FCFrank Cecchin
Frank Cecchin
EWEdward P. Walsh
Edward P. Walsh


7 June 2018 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
TBTrevor Birkey
Trevor Birkey
JDJennifer Dixon
Jennifer Dixon
RJRoni Jacobsen
Roni Jacobsen
SGSalil Ginde
Salil Ginde
MNMelodee Nugent
Melodee Nugent
JKJoshua Kovach
Joshua Kovach

17 November 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
CPCaitlin Pook
Caitlin Pook
EKEvelyn Kuhn
Evelyn Kuhn
ASAnoop Singh
Anoop Singh
JKJoshua Kovach
Joshua Kovach

1 October 2025 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
CMChristina Y. Miyake
Christina Y. Miyake
DKDania Kallas
Dania Kallas
SSSara B. Stephens
Sara B. Stephens
OMOliver Moore
Oliver Moore
Xander WehrensXander Wehrens
Xander Wehrens
SSShubhayan Sanatani
Shubhayan Sanatani
BACKGROUND: Marked intellectual and neurodevelopmental delay (INDD) was noted in 6 unrelated patients diagnosed with RYR2 -related catecholaminergic polymorphic ventricular tachycardia (CPVT) from a single center. Patients exhibited similar distinct phenotypic features not previously described. We aimed to determine the prevalence of INDD in CPVT, compare clinical characteristics between patients with CPVT with and without INDD, and investigate the possibility of a unique neurocardiac CPVT phenotype. METHODS: Retrospective combined review of patients with RYR2 -related CPVT diagnosed ≤18 years with and without INDD from a single center and the International Pediatric CPVT Registry. Patients with hypoxic ischemic insult were excluded unless INDD preceded injury. RESULTS: Among a total of 168 patients, INDD was reported in 19 (11.3% [95% CI, 7.0%–17.1%]). When compared with cases without INDD, patients with INDD exhibited distinct features including (1) younger age at onset of symptoms (median 7.0 versus 10.0 years; P =0.04); (2) higher frequency of atrial tachyarrhythmias (84.2% versus 16.3%, P <0.001); (3) atrial or ventricular tachycardia without adrenergic stimulation (81.3% versus 2.2%, P <0.001, 31.6% versus 4.5%, P =0.001 respectively); (4) cardiac structural changes or systolic dysfunction (36.8% versus 1.3%, P <0.001); and (5) higher incidence of cardiac arrest or sudden death after diagnosis (26.3% versus 2.7%, P =0.001). INDD-related RYR2 genetic variants clustered within the central and channel domains and may be specific to certain variants. CONCLUSIONS: This study demonstrates a wider spectrum of RYR2 -related disease, with a subset associated with extracardiac manifestations. Certain RYR2 variants may lead to a neurocardiac phenotype with distinct features that are important to recognize, as these patients may be at higher risk.